CHM-MSU MD/PhD Program
Established in 1985, the CHM MD/PhD program is a seven-year program through which a small number of academically capable, highly motivated students earn both the MD and PhD degrees.
The training program begins the summer immediately prior to the first year of medical school, with participation in laboratory rotations, concurrently taking a selection of medical and graduate school courses through the first three years following a schedule specifically tailored to them. This provides the opportunity to begin the graduate program while getting to know both their MD and PhD classmates. During the summer between Years 3 and 4, the student sits for the USMLE Step I Exam (boards). Years 4 and 5 are devoted to dissertation research. Once the PhD is completed, the student begins their clinical clerkships.
Unique to this program is the introduction of the Integrated Clinical Experience during the PhD training years. MD/PhD students stay in touch with their medical colleagues and medical training through participation in a monthly continuity clinic assignment in a clinic of interest as selected by the student.
To assure successful completion of the program, each student's progress is reviewed regularly by the MD/PhD program director, the graduate program director, their research mentor, and the graduate thesis committee.
Students in the CHM-MSU MD/PhD Program will be placed at the East Lansing preclinical campus for their preclinical course work and at the Grand Rapids community campus for their clinical clerkship training.
Graduate Study Options
The MSU Graduate School is where applicants apply to the graduate program of their choice. The site includes links to all MSU PhD programs. The MSU CHM MD/PhD program encourages applications from candidates interested in fields other than the traditional biomedical sciences.
Additionally, The BioMolecular Science Gateway offers admission to 6 graduate programs: Biochemistry and Molecular Biology, Cell and Molecular Biology, Genetics, Microbiology and Molecular Genetics, Pharmacology and Toxicology, and Physiology
Financial support for the CHM-MSU MD/PhD program comes from Spectrum Health, with funded fellowships to two incoming students per year. The Spectrum Health Fellows are provided with a financial package to cover health care, partial tuition, some travel, and a stipend during the five years of medical school training. The graduate programs are expected to support the student during the PhD research years.
Information on some of the PhD programs associated with CHM can be found on the CHM Graduate Degree Program page. Prospective students are encouraged to communicate directly with the programs or departments of interest. Prospective students may also direct inquiries to nonbiological science programs with approval from the MD/PhD director.
CHM-MSU Application Process
Application and Eligibility
An applicant must apply for admission to CHM through the American Medical College Application Service (AMCAS) as a Combined Medical Degree/PhD applicant. At the same time, the applicant must submit an application to the MSU Graduate School.
If the applicant is deemed eligible for acceptance by both CHM and a graduate program, their application will be reviewed by the CHM-MSU MD/PhD Selection Committee for a final decision. If accepted by the CHM-MSU MD/PhD Selection Committee, the applicant will be offered a position in the CHM-MSU MD/PhD program.
Applicants invited to join the CHM MD/PhD program by the CHM-MSU MD/PhD Selection Committee will receive a formal acceptance from the College of Human Medicine and the applicable graduate department. An applicant who is not selected for acceptance by the CHM-MSU MD/PhD Selection Committee is not eligible for a seat as an MD degree-only student.
Interested applicants should:
Apply to the College of Human Medicine through the American Medical College Application Service (AMCAS) as a Combined Medical Degree/PhD type applicant
Submit an application to the MSU Graduate School no later than November 1. Be sure to submit all supporting documentation.
Take (or retake, if necessary) the Medical College Admissions Test (MCAT) by September 12, 2013.
To be competitive for the limited number of MD/PhD fellowships, application materials including MCAT scores, letters of evaluation, graduate program preference, Secondary Application, and Graduate School application should be submitted early. Review of applications begins in July.
Letters of Evaluation
All applicants to the CHM MD/PhD program are expected to have a minimum of four letters submitted through the AMCAS Letters service. Applicants should request three letters of recommendation for the MD/PhD program component, from individuals who can attest to the applicant's qualifications for the MD/PhD Program, as well as their motivation and ability to conduct research.
To address the MD component more specifically, applicants should submit at least one letter that reflects their medical/clinical interest and experience and can address personal characteristics consistent with an excellent physician. Applications will not be reviewed until all letters are received.
CHM-MSU interviews take place in East Lansing. Applicants are interviewed separately for each program by members of the respective interview panels. CHM-MSU interviews are arranged by the CHM Office of Admissions and the PhD interview will be held on or near the day of the applicant’s CHM interview.
During the CHM interview, the applicant is interviewed by one faculty member and one CHM student and tours the medical school.
During the PhD interview, the applicant is interviewed by a research faculty, given a tour of the research facilities, and given the opportunity to meet with appropriate faculty and current MD/PhD students during their visit.
The applicant will also be interviewed by the Director and/or Assistant Director of the MD/PhD Program.
Applicants will be notified of a decision as soon as possible. Admission to the College of Human Medicine MD program is contingent upon acceptance by the CHM-MSU MD/PhD Program Selection Committee.